From the publishers of JADPRO

DLBCL Resource Center

Advertisement

Interview With Ashley Ames, MSN, RN, FNP-BC, OCN: DLBCL Highlights from the 2025 American Society of Clinical Oncology Annual Meeting

Interview With James O. Armitage, MD: From Provider to Caregiver to Patient—Lessons Learned

DLBCL Highlights from the 2024 American Society of Hematology Annual Meeting

Interview with Matthew Lunning, DO, FACP: Best Practices for BiTE Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Interview With Sharyn Kurtz, PA-C: Health Disparities and Inequalities in the Global DLBCL Landscape

Interview with Sharyn Kurtz, PA-C: Challenges and Opportunities in the Management of Elderly Patients With DLBCL

Interview With Ashley Schmitt, PA-C: Clinical Recommendations and Toxicity Management With BiTE Therapy for Relapsed/Refractory DLBCL

Interview With Amy Goodrich, RN, BSN, MSN, CRNP-AC: Management of Aggressive High-Grade Lymphomas

Interview With Amy Goodrich, RN, BSN, MSN, CRNP-AC: The Alphabet Soup in the Pathobiology of DLBCL

Interview With Christopher D'Angelo, MD: Current Treatment Landscape for R/R DLBCL

Interview With Christopher D’Angelo, MD: Current Frontline Treatment of DLBCL Beyond R-CHOP

Interview With Gilles Salles, MD, PhD: Novel Treatments in DLBCL

Interview With Shani Irby, ANP-BC: CAR T-Cell Therapy in DLBCL

Interview With Shani Irby, ANP-BC: Relapsed DLBCL and the Role of Autologous Stem Cell Transplant

Interview With Andréa LeVoir, PharmD, BCOP: First-Line Treatment in DLBCL

Interview With Susan K. Seo, MD: COVID-19 Considerations for Patients With DLBCL

Interview With Emily Panzner, MSN, AGNP-BC: Introduction to DLBCL

Primary Diffuse Large B-Cell Lymphoma of the Bone

Unraveling the Enigma: A Case Study on Primary CNS Lymphoma

Relapsed DLBCL After CAR T-Cell Therapy

Fast Facts #12: Long-Term Survivorship